| Literature DB >> 24001787 |
Sarah Tonkin-Crine1, Felicity L Bishop, Matthew Ellis, Rona Moss-Morris, Hazel Everitt.
Abstract
BACKGROUND: Cognitive behavioral therapy (CBT) has been shown to have positive effects on the management of irritable bowel syndrome (IBS) symptoms. A factorial pilot randomized placebo-controlled trial (called MIBS) tested the potential effectiveness of a self-management CBT-based website alongside two medications: methylcellulose and mebeverine, and a placebo. The results showed no significant differences in quality of life or symptom severity measures, but enablement and participant's global assessment of relief was higher in the website groups.Entities:
Keywords: Internet; cognitive behaviour therapy; irritable bowel syndrome; primary care; qualitative research
Mesh:
Substances:
Year: 2013 PMID: 24001787 PMCID: PMC3785978 DOI: 10.2196/jmir.2672
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1A MIBS webpage that gives participants an example of how thoughts, behaviors, emotions, and symptoms can interact.
Figure 2Flowchart showing how participants were identified from the original trial group.
Characteristics of 31 participants who took part in interviews compared to the 60 participants who received access to the Regul8 website in the main trial.
| Characteristics |
| 31 participants interviewed | 60 participants who refused or who did not take part in interviews | Significant differences between the two groups ( | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Male | 15 (49) | 13 (22) |
|
|
|
| Female | 16 (51) | 47 (78) |
|
|
|
|
|
|
| Not significant |
|
|
| Mean average | 51 | 43 |
|
|
|
| SD | 8.6 | 9.4 |
|
|
|
| Range | 34-61 | 22-60 |
|
|
|
|
|
|
| Not significant |
|
|
| White British | 28 (91) | 55 (95) |
|
|
|
| White other | 2 (6) | 3 (3) |
|
|
|
| Indian | 0 (0) | 1 (1) |
|
|
|
| Unknown | 1 (3) | 1 (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Not significant | ||
|
|
| Mean average | 241.6 | 237.6 |
|
|
|
| Range | 85-461 | 75-470 |
|
|
|
|
| Not significant | ||
|
|
| Mean average | 59.6 | 65.2 |
|
|
|
| Range | 18.38-88.97 | 20.59-96.32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| Not significant | ||
|
|
| Website with nurse support | 16 (51) | 30 (50) |
|
|
|
| Website only | 15 (49) | 30 (50) |
|
|
|
|
|
|
| Not significant |
|
|
| Mean average sessions completed | 5.2 out of 8 | 3.7 out of 8 |
|
|
|
|
|
| ||
|
|
| Yes (compliant) | 21 (71) | 30 (50) |
|
|
|
| No (non-compliant) | 9 (29) | 30 (50) |
|
aIBS symptom severity score indicates self-reported severity of symptoms by participants at baseline; higher scores represent more severe symptoms.
bIBS quality of life score indicates self-reported quality of life by participants at baseline; higher scores represent better quality of life.
Figure 3Thematic map identifying the 3 types of patient engagement with the Regul8 website.
Participant characteristics for each of the three types of engagement identified.
| Type | Number | Participant characteristics |
| Limited or no engagement with website | 10 | 6 /10 compliant with the website. Completed on average 4.4 sessions out of 8. 2/10 participants received nurse telephone support |
| Engagement with content on practical lifestyle changes | 6 | 4/6 compliant with the website. Completed on average 5.1 sessions out of 8. 4/6 received nurse telephone support |
| Engagement with content on emotions and thoughts | 12 | 11/12 compliant with the website. Completed on average 6.4 out of 8. 8/12 received nurse telephone support. |